Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with

Hailiang Wu1, Horacio Cabral1, Kazuko Toh2

  • 1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

Insights

Polymeric micelles loaded with (1,2-diaminocyclohexane)platinum(II) (DACHPt) effectively treated liver metastases. These nanocarriers targeted both overt and preangiogenic metastases by exploiting tumor neovasculature and inflammatory microenvironments, respectively.

Area of Science:

  • Oncology
  • Materials Science
  • Pharmacology

Background:

  • Nanocarriers enhance drug delivery to solid tumors via the enhanced permeability and retention (EPR) effect.
  • Metastasis is a primary cause of cancer mortality, yet nanocarrier targeting of early-stage, preangiogenic micrometastases remains poorly understood.
  • Conventional nanocarriers rely on tumor neovasculature for accumulation, limiting their efficacy against nascent metastatic sites.

Purpose of the Study:

  • To investigate the efficacy of micellar nanocarriers loaded with (1,2-diaminocyclohexane)platinum(II) (DACHPt) for treating liver metastases.
  • To evaluate the targeting mechanisms of these nanocarriers in both overt and preangiogenic metastatic stages.
  • To explore the potential of nanocarriers for early detection and treatment of metastatic disease.

Main Methods:

  • Development of micellar nanocarriers encapsulating DACHPt (DACHPt/m).
  • Intravenous administration of DACHPt/m in a murine colon adenocarcinoma (C-26) liver metastasis model.
  • Assessment of tumor growth inhibition and nanocarrier accumulation in both overt and preangiogenic metastatic stages.
  • Analysis of the correlation between nanocarrier targeting and tumor microenvironment characteristics.

Main Results:

  • DACHPt/m significantly inhibited tumor growth in both overt and preangiogenic liver metastasis models.
  • Targeting of overt metastases was attributed to selective accumulation in neovasculature-rich cancerous tissues.
  • Targeting of preangiogenic metastases was linked to the inflammatory microenvironment of the metastatic niche.
  • Demonstrated nanocarrier accumulation and therapeutic effect in early-stage metastatic lesions.

Conclusions:

  • Polymeric micelles loaded with DACHPt are effective against liver metastases at different stages of development.
  • Nanocarrier targeting mechanisms differ between overt (neovasculature-dependent) and preangiogenic (inflammatory microenvironment-dependent) metastases.
  • This study highlights a novel strategy for targeting preangiogenic micrometastases, potentially enabling earlier diagnosis and treatment of cancer spread.

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K